Reinhart Partners, Inc. Syneos Health, Inc. Transaction History

Reinhart Partners, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 01, 2023	SELL	$34.5 - $42.19 $3.49 Million - $4.26 Million	-101,050 Reduced 23.59%	327,376 $13.8 Million
Q1 2023 Apr 26, 2023	BUY	$33.32 - $40.98 $14.3 Million - $17.6 Million	428,426 New	428,426 $15.3 Million
Q4 2022 Jan 18, 2023	BUY	$25.32 - $51.45 $144,678 - $293,985	5,714 Added 1.41%	410,266 $15 Million
Q3 2022 Nov 01, 2022	BUY	$46.5 - $79.14 $3.55 Million - $6.05 Million	76,396 Added 23.28%	404,552 $19.1 Million
Q2 2022 Jul 27, 2022	BUY	$63.06 - $84.75 $5.75 Million - $7.73 Million	91,151 Added 38.46%	328,156 $23.5 Million
Q1 2022 Apr 20, 2022	BUY	$74.15 - $99.36 $549,896 - $736,853	7,416 Added 3.23%	237,005 $19.2 Million
Q4 2021 Jan 27, 2022	SELL	$86.01 - $102.89 $5.88 Million - $7.04 Million	-68,392 Reduced 22.95%	229,589 $23.6 Million
Q3 2021 Oct 20, 2021	SELL	$84.7 - $96.31 $11.6 Million - $13.2 Million	-137,340 Reduced 31.55%	297,981 $26.1 Million
Q2 2021 Jul 21, 2021	BUY	$76.44 - $89.57 $1.61 Million - $1.89 Million	21,059 Added 5.08%	435,321 $39 Million
Q1 2021 Apr 22, 2021	BUY	$67.36 - $80.76 $12.2 Million - $14.7 Million	181,442 Added 77.93%	414,262 $31.4 Million
Q4 2020 Jan 25, 2021	BUY	$53.08 - $69.86 $12.4 Million - $16.3 Million	232,820 New	232,820 $15.9 Million

731K

Ticker SYNH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 102,653,000
Description
Syneos Health, Inc. provides biopharmaceutical outsourcing solutions company in North America, Europe, the Middle East, Africa, the Asia-Pacific, and Latin America. It operates through two segments, Clinical Solutions and Commercial Solutions. The Clinical Solutions segment offers services for the development of diagnostics, drugs, biologics, de...

Get notified when there are updates to the investment portfolio of Reinhart Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Reinhart Partners, Inc. with notifications on news.